Fierce Biotech7d
Pfizer adds J&J, BMS vet James List to its executive roster as new chief internal medicine officer
Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment ...
Pfizer appoints former J&J executive to lead obesity drug development
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Pfizer boosts anti-obesity efforts: adds former J&J exec. as chief internal medicine officer
Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal ...
Pfizer names James List Chief Internal Medicine Officer
Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...
The Pharma Letter4d
Pfizer lures former J&J exec to be its CIMO
US pharma giant Pfizer (NYSE: PFE) today announced that James List, has joined the company as chief internal medicine officer ...
Posts falsely claim Pfizer published list of Covid-19 vaccine side effects
Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...
BioPharma Dive7d
Roche launches new Boston center; NIH centralizes peer review
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...
Pfizer Appoints Ex-J&J Leader to Accelerate Weight Loss Solutions
Pfizer Supercharges Obesity Battle with Top J&J Exec ...
Pfizer appoints former J&J executive to lead development of obesity medicines
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Seeking Alpha7d
Pfizer boosts anti-obesity efforts: adds former J&J exec. as chief internal medicine officer
Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal medicine officer to boost the company's efforts in obesity drug ...